Medical Research
Latest News
What Vinay Prasad’s ouster means for biotech and the FDA
Elaine Chen covers biotech, co-writes The Readout newsletter , and co-hosts STAT’s weekly biotech podcast, The Readout Loud . You can reach Elaine on...
STAT+: Representatives of expert groups to be barred from work supporting CDC’s vaccine advisers
Helen Branswell covers issues broadly related to infectious diseases, including outbreaks, preparedness, research, and vaccine development. Follow her...
STAT+: Jay Bhattacharya once studied health disparities. As NIH director, he’s allowed such research to wither
The April announcement of National Institutes of Health director Jay Bhattacharya’s appointment and his public profile at Stanford University, where h...
Opinion: The U.S. needs a revolution to harness the potential of GLP-1s for weight loss
The introduction of the GLP-1 class of medications for weight loss has, to date, been one of the rockiest rollouts of a major medical advance in the U...
Opinion: The FDA’s plan on fluoride supplements is bad science
One of the most important lessons from the Covid-19 experience is that absolutes in scientific discourse are the exception. Science evolves as both co...
STAT+: MAGA influencers take a sudden interest in Medicare Advantage reforms, echoing a dark money group
Casey Ross covers the use of artificial intelligence in medicine and its underlying questions of safety, fairness, and privacy. John Wilkerson is a Wa...
Childhood vaccination rates fall again, raccoons are not friends, and more health news
O. Rose Broderick reports on the health policies and technologies that govern people with disabilities’ lives. Before coming to STAT, she worked at WN...
STAT+: Pharmalittle: We’re reading about Trump demands on drug prices, a 340B pilot program, and much more
Ed Silverman, a senior writer and Pharmalot columnist at STAT, has been covering the pharmaceutical industry for nearly three decades. He is also the...
STAT+: Trump demands drugmakers slash U.S. price now
Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. Good morning, and happy bi...
FDA to stress opioids’ risk of overdose, death in new medication safety labels
The Food and Drug Administration will soon require prescription opioid manufacturers to include stronger language on the medications’ labels warning t...
What Vinay Prasad’s ouster means for biotech and the FDA
STAT+: Representatives of expert groups to be barred from work supporting CDC’s vaccine advisers
STAT+: Jay Bhattacharya once studied health disparities. As NIH director, he’s allowed such research to wither
Opinion: The U.S. needs a revolution to harness the potential of GLP-1s for weight loss
Opinion: The FDA’s plan on fluoride supplements is bad science
STAT+: MAGA influencers take a sudden interest in Medicare Advantage reforms, echoing a dark money group
Childhood vaccination rates fall again, raccoons are not friends, and more health news
STAT+: Pharmalittle: We’re reading about Trump demands on drug prices, a 340B pilot program, and much more
STAT+: Trump demands drugmakers slash U.S. price now
FDA to stress opioids’ risk of overdose, death in new medication safety labels
Advertisement
300x250 Banner
Recent Content
COPD Biologics: Early Treatment Insights
Pulmonology • 2 hours ago
Antihypertensive Medication Guidelines
Cardiology • 4 hours ago
Juvenile Arthritis Care Transition
Rheumatology • 6 hours ago